Metabolic outcomes of matched patient populations initiating exenatide BID vs. insulin glargine in an ambulatory care setting
出版年份 2012 全文链接
标题
Metabolic outcomes of matched patient populations initiating exenatide BID vs. insulin glargine in an ambulatory care setting
作者
关键词
-
出版物
DIABETES OBESITY & METABOLISM
Volume 14, Issue 7, Pages 626-633
出版商
Wiley
发表日期
2012-02-10
DOI
10.1111/j.1463-1326.2012.01581.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A comparison of costs among patients with type 2 diabetes mellitus who initiated therapy with exenatide or insulin glargine
- (2012) Derek Misurski et al. Applied Health Economics and Health Policy
- One-year treatment with exenatide vs. Insulin Glargine: Effects on postprandial glycemia, lipid profiles, and oxidative stress
- (2010) Mathijs C. Bunck et al. ATHEROSCLEROSIS
- One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice
- (2010) M. Buysschaert et al. DIABETES & METABOLISM
- Weight Loss, Glycemic Control, and Changes in Cardiovascular Biomarkers in Patients With Type 2 Diabetes Receiving Incretin Therapies or Insulin in a Large Cohort Database
- (2010) E. S. Horton et al. DIABETES CARE
- Exenatide Affects Circulating Cardiovascular Risk Biomarkers Independently of Changes in Body Composition
- (2010) M. C. Bunck et al. DIABETES CARE
- Durability of Effects of Exenatide Treatment on Glycemic Control, Body Weight, Systolic Blood Pressure, C-Reactive Protein, and Triglyceride Concentrations
- (2010) Ajay Varanasi et al. Endocrine Practice
- A review of exenatide as adjunctive therapy in patients with type 2 diabetes
- (2010) Gisela Robles Drug Design Development and Therapy
- Healthcare resource utilization and costs assessment of type 2 diabetes patients initiating exenatide BID or glargine: a retrospective database analysis
- (2010) Manjiri Pawaskar et al. JOURNAL OF MEDICAL ECONOMICS
- Patient characteristics, drug adherence patterns, and hypoglycemia costs for patients with type 2 diabetes mellitus newly initiated on exenatide or insulin glargine
- (2009) Rosalind Fabunmi et al. CURRENT MEDICAL RESEARCH AND OPINION
- One-Year Treatment With Exenatide Improves -Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients: A randomized, controlled trial
- (2009) M. C. Bunck et al. DIABETES CARE
- Six-month outcomes on A1C and cardiovascular risk factors in patients with type 2 diabetes treated with exenatide in an ambulatory care setting
- (2009) D. I. Brixner et al. DIABETES OBESITY & METABOLISM
- Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study
- (2009) M. J. Davies et al. DIABETES OBESITY & METABOLISM
- Improved Glycemic Control and Reduction of Cardiometabolic Risk Factors in Subjects with Type 2 Diabetes and Metabolic Syndrome Treated with Exenatide in a Clinical Practice Setting
- (2009) Rajat Bhushan et al. Diabetes Technology & Therapeutics
- A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003
- (2007) Peter C. Austin STATISTICS IN MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search